Lb Pharmaceuticals (LBRX) Accumulated Depreciation (2024 - 2026)

Lb Pharmaceuticals' Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $502000.0 for Q1 2026.

• In Q1 2026, Accumulated Depreciation changed N/A year-over-year to $502000.0; the TTM figure through Mar 2026 stood at $502000.0 (changed N/A YoY), while the FY2025 annual figure was $420000.0, up 315.84% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $502000.0, up from $420000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation was $502000.0 in Q1 2026, with the low at $101000.0 in Q4 2024.
• The 3-year median for Accumulated Depreciation is $378500.0 (2025), against an average of $340000.0.
• Peak annual rise in Accumulated Depreciation reached 315.84% in 2025, while the deepest fall reached 315.84% in 2025.
• Lb Pharmaceuticals' Accumulated Depreciation stood at $101000.0 in 2024, then soared by 315.84% to $420000.0 in 2025, then rose by 19.52% to $502000.0 in 2026.
• Business Quant data shows LBRX's Accumulated Depreciation at $502000.0 in Q1 2026, $420000.0 in Q4 2025, and $337000.0 in Q3 2025.